GateFinder

GateFinder identifies optimal sequences of two-marker polygon gates on two-dimensional scatter plots to isolate and enrich target cell populations from high-parameter single-cell datasets for validation with lower-parameter assays.


Key Features:

  • Simplified enrichment strategy: Enables isolation and enrichment of specific cell populations from high-dimensional single-cell data using stepwise gating.
  • Stepwise polygon gates: Constructs a sequence of polygonal gates that operate on two-dimensional scatter plots using only two markers per gate.
  • Cluster-membership driven selection: Analyzes a vector of cluster memberships to guide identification of gates that enrich the target cell type.
  • Compatibility with high-parameter data: Leverages high-parameter single-cell technologies as the input basis for deriving lower-parameter gating strategies.

Scientific Applications:

  • Efficient assay design: Supports design of lower-parameter validation assays by providing simple gating sequences to enrich target populations.
  • Novel biomarker discovery: Facilitates isolation of specific cell subsets to enable downstream identification of candidate biomarkers.
  • Clarification of biological mechanisms: Aids investigation of cellular heterogeneity and distinct cell types through targeted enrichment.

Methodology:

GateFinder analyzes a vector of cluster memberships and identifies an optimal sequence of polygonal gates on 2D scatter plots, each gate defined by two markers, to isolate the desired cell type.

Topics

Collections

Details

License:
Artistic-2.0
Tool Type:
library
Operating Systems:
Linux, Windows, Mac
Programming Languages:
R
Added:
7/9/2018
Last Updated:
11/25/2024

Operations

Publications

Aghaeepour N, Simonds EF, Knapp DJHF, Bruggner RV, Sachs K, Culos A, Gherardini PF, Samusik N, Fragiadakis GK, Bendall SC, Gaudilliere B, Angst MS, Eaves CJ, Weiss WA, Fantl WJ, Nolan GP. GateFinder: projection-based gating strategy optimization for flow and mass cytometry. Bioinformatics. 2018;34(23):4131-4133. doi:10.1093/bioinformatics/bty430. PMID:29850785. PMCID:PMC6247943.

PMID: 29850785
PMCID: PMC6247943
Funding: - Ovarian Cancer Research Fund: OCRF 292495 - Postdoctoral Fellowship: CIHR 321510 - Damon Runyon Cancer Research Foundation Postdoctoral Fellowship: DRG 2190-14 - National Institute of Health: T32GM007276 - NIH: 0158GKB065, 1R01CA130826, 1R33CA183692-01, 41000411217, 5-24927, 5U54CA143907, HHSN272200700038C, N01-HV-00242, P01 CA034233-22A1, PN2EY018228, RFA CA 09-009, RFA CA 09-011, U19 AI057229, U54CA149145 - California Institute for Regenerative Medicine: DR1-01477, RB2-01592 - European Commission: HEALTH.2010.1.2-1 - FDA: BAA-12-00118, HHSF223201210194C - Terry Fox Foundation Program Project: TFF 122869

Documentation

Downloads

Links